GlassScriptPhysician profile
Joniruth B Digaum
NPI 1881017382
$2,380.07
in general payments reported to CMS, 2019-2025
17 companies · $500 in 2025
The $500 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $188 · 2022: $278 · 2023: $509 · 2024: $905 · 2025: $500.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,711 · Education: $203.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,710.76 |
| Education | $202.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $455.71 | 2022-2024 | |
| Janssen Pharmaceuticals, INC | $406.97 | 2021-2025 | Invega Sustenna |
| Teva Pharmaceuticals USA, INC. | $351.91 | 2022-2025 | Uzedy, Austedo Xr, Austedo Xr |
| Supernus Pharmaceuticals, INC. | $249.71 | 2023-2024 | Qelbree, Qelbree |
| Otsuka America Pharmaceutical, INC. | $209.32 | 2022-2025 | Abilify Asimtufii, Rexulti, Abilify Maintena |
| Neurocrine Biosciences, INC. | $137.94 | 2023-2025 | Ingrezza |
| Vanda Pharmaceuticals INC. | $126.77 | 2024-2025 | Fanapt |
| Alkermes, INC. | $89.79 | 2021-2023 | Aristada, Lybalvi |
| E.R. Squibb & Sons, L.L.C. | $88.50 | 2024-2025 | Cobenfy |
| Sunovion Pharmaceuticals INC. | $62.01 | 2021-2022 | |
| Corium, LLC | $58.22 | 2023-2025 | Azstarys |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $37.71 | 2021-2023 | |
| Axsome Therapeutics, INC. | $35.96 | 2024-2025 | Auvelity |
| Indivior INC. | $19.54 | 2022 | |
| Merck Sharp & Dohme LLC | $18.35 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $17.80 | 2021 | |
| Lundbeck LLC | $13.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joniruth Digaum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.